Lack of Inhibitor Development After Switching to Rurioctocog Alfa Pegol in the American Thrombosis and Hemostasis Network (ATHN) 2: Factor Switching Study

Janna Journeycake, Jorge Caicedo, Dunlei Cheng, Michael Denne, Christine Guelcher, Susan Lattimore, Margaret Ragni, Michael Recht, Robert Sidonio Jr, Clifford Takemoto, Michael Tarantino, Crystal Watson, Ellis J Neufeld
International Society on Thrombosis and Haemostasis (ISTH) 2020 Virtual Congress
July 12-14, 2020
Inhibitors, RWD (Real world data), FDA

Can’t find what you’re looking for?
Please contact for assistance.